Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Sunmax Biotechnology
Sunmax Biotechnology
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Sunmax Biotechnology
Stock Price
NT$266.5
2024-10-29
Market Capitalization
NT$14.5 B
2024-10-29
Revenue
NT$2 B
FY, 2025
Sunmax Biotechnology Summary
Company Summary
Overview
Sunmax Biotechnology is a company that manufactures and markets collagen-based medical devices. It offers dermal filler, dental, orthopedic, skincare, laboratory, and other product categories.
Type
Public
Status
Active
Founded
2001
Website
https://www.sunmaxbiotech.com/
Cybersecurity rating
Sectors
Healthcare
biotech
medical devices
Homepage
Linkedin
Table of Contents
Financials
Competitors
Sunmax Biotechnology Financials
Summary Financials
Revenue (Q1, 2026)
NT$564.8M
Gross profit (Q1, 2026)
NT$480.7M
Net income (Q1, 2026)
NT$221.6M
Cash (Q1, 2026)
NT$1.1B
EBIT (Q1, 2026)
NT$297.0M
Enterprise value
$13.5B
Competitors and Similar Companies
Promed
Healthcare - Private
BioPerfectus
Healthcare - Public
Tarsons Products
Healthcare - Public
Poly Medicure
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top